Publications en collaboration avec des chercheurs de Odense University Hospital (15)

2023

  1. International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design

    American Heart Journal, Vol. 257, pp. 41-50

2022

  1. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1852-1862

  2. First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

    British Journal of Cancer, Vol. 126, Núm. 11, pp. 1548-1554

2021

  1. Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

    European Journal of Cancer, Vol. 158, pp. 156-168

  2. Thin- versus thick-strut polymer-free biolimus-eluting stents: The BioFreedom QCA randomised trial

    EuroIntervention, Vol. 17, Núm. 3, pp. 233-239

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

    Annals of Oncology, Vol. 31, Núm. 9, pp. 1160-1168

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2017

  1. A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation

    Leukemia and Lymphoma, Vol. 58, Núm. 1, pp. 153-161

  2. Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: A randomized phase III trial - FIRSTANA

    Journal of Clinical Oncology, Vol. 35, Núm. 28, pp. 3189-3197

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy

    International Archives of Allergy and Immunology, Vol. 166, Núm. 1, pp. 41-51

2012

  1. Fast: Towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

    Clinical and Translational Allergy, Vol. 2, Núm. 1

  2. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2010

  1. Pemetrexed safety and pharmacokinetics in patients with third-space fluid

    Clinical Cancer Research, Vol. 16, Núm. 10, pp. 2872-2880